Trial of 2nd Generation Anti-CEA Designer T Cells in Metastatic Breast Cancer
Clinical trial NCT00673829 · SUSPENDED
Trial details
- NCT number
- NCT00673829
- Sponsor
- Roger Williams Medical Center
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2017-12-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.